Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yodaiken, R.
Right arrow Articles by Bennett, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yodaiken, R.
Right arrow Articles by Bennett, D
American Journal of Hospital Pharmacy, Vol 43, Issue 5, 1193-1204
Copyright © 1986 by American Society of Health-System Pharmacists


Articles

OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Occupational Safety and Health Administration

RE Yodaiken and D Bennett


Work-practice guidelines for personnel dealing with cytotoxic drugs (CDs) are presented. Current practices in the preparation, storage, administration, and disposal of CDs may expose pharmacists, nurses, physicians, and other health-care workers to high environmental levels of these drugs. OSHA has developed these guidelines to protect health-care workers from unnecessary exposure to CDs. A brief summary of the short-term and long-term hazards known to be associated with these drugs is presented. The risks to workers handling CDs are a combined result of the drugs' inherent toxicity and the extent to which workers are directly exposed to CDs via inhalation, absorption, and ingestion. Work-practice guidelines that can limit the exposure of workers to CDs and the equipment necessary to carry out these practices properly are described.
 



This article has been cited by other articles:


Home page
J Oncol Pharm PractHome page
C. M. Beaupin and R. Darmanaden
Quality control in a centralized reconstitution unit of cytotoxic agents: Determination of etoposide using high-performance thin-layer chromatography
Journal of Oncology Pharmacy Practice, January 1, 1996; 2(1): 35 - 41.
[Abstract] [PDF]


Home page
Journal of Pharmacy PracticeHome page
J. F. Gallelli
Issues and Risks Associated With Handling Antineoplastic Drugs
Journal of Pharmacy Practice, January 1, 1991; 4(1): 72 - 76.
[PDF]


Home page
Journal of Pharmacy PracticeHome page
T. L. Pipp, L. Mellott, and S. Calvert
Integration of Standards Into Hospital Pharmacy Practice (for the Pharmacist)
Journal of Pharmacy Practice, August 1, 1988; 1(1): 29 - 40.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society of Health-System Pharmacists.